Medical surgical unit admission with community acquired c-diff - Nursing Case Study
Pathophysiology
• Primary mechanism: Antibiotic disruption of normal gut flora allows Clostridioides difficile spores to germinate, leading to overgrowth and toxin production in the colon, causing inflammation and diarrhea.
• Secondary mechanism: Toxin A and Toxin B released by C. difficile damage the intestinal mucosa by breaking down epithelial cell junctions, resulting in increased intestinal permeability and further inflammation.
• Key complication: Severe cases can progress to pseudomembranous colitis, characterized by the formation of pseudomembranes on the colon lining, which may lead to complications like toxic megacolon or perforation, necessitating immediate medical intervention.
Patient Profile
Demographics:
65-year-old female, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Osteoarthritis
• Current medications: Lisinopril, Metformin, Acetaminophen
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe diarrhea and abdominal pain
• Key symptoms: Frequent watery stools, fever, nausea, dehydration
• Vital signs: Temperature 101.3°F, Heart rate 110 bpm, Blood pressure 95/60 mmHg, Respiratory rate 24 breaths per minute, Oxygen saturation 94% on room air
Section 1
As the initial assessment of the patient continues, the nurse notes several key findings that indicate the progression of the illness. The patient's abdominal examination reveals diffuse tenderness with hypoactive bowel sounds, suggesting decreased intestinal motility, which could precede more severe complications like ileus or toxic megacolon. The skin is noted to be dry, and mucous membranes are parched, consistent with significant dehydration due to ongoing diarrhea. The patient's vital signs demonstrate persistent tachycardia with a heart rate of 112 bpm, hypotension with a blood pressure reading of 90/55 mmHg, and mild tachypnea at 26 breaths per minute. These signs suggest a compensatory response to hypovolemia and potential early stages of septic shock, necessitating close monitoring and fluid resuscitation.
Laboratory results further detail the patient's condition. A complete blood count (CBC) reveals leukocytosis, with a white blood cell count of 18,000 cells/mm³, indicating an inflammatory response. Electrolyte panels show hypokalemia and hyponatremia, consequences of excessive gastrointestinal losses, which could contribute to cardiac arrhythmias and muscle weakness if not corrected. Serum lactate levels are elevated at 3.0 mmol/L, raising concerns about tissue hypoperfusion and anaerobic metabolism, further complicating her clinical picture. A stool sample has confirmed the presence of C. difficile toxins, solidifying the diagnosis and guiding the antibiotic treatment plan.
Despite initiating treatment with oral vancomycin and intravenous fluids, the patient's condition shows signs of deterioration. Her mental status has shifted from alert to lethargic, raising concerns about worsening metabolic disturbances or early septic encephalopathy. Oxygen saturation has decreased to 92% on room air, prompting the need for supplemental oxygen to maintain adequate saturation levels. These developments necessitate a reevaluation of the treatment plan, considering potential escalation to more aggressive interventions, such as surgical consultation for possible pseudomembranous colitis or toxic megacolon. The healthcare team must now engage in critical clinical reasoning to prioritize interventions that address both the infection and emerging complications to stabilize the patient.
Section 2
As the patient's condition continues to evolve, the healthcare team remains vigilant for any new developments. Despite the ongoing administration of oral vancomycin and intravenous fluids, the patient's lethargy progresses, and her oxygen saturation on supplemental oxygen via nasal cannula remains marginally sufficient at 94%. In response to these concerning changes, the team orders a repeat set of laboratory tests and an abdominal CT scan to evaluate for complications such as ileus or toxic megacolon.
The CT scan reveals significant colonic distension with wall thickening, indicative of potential pseudomembranous colitis. This finding underscores the need for a more aggressive treatment strategy and prompts a surgical consultation to assess the risk of toxic megacolon, which could necessitate urgent surgical intervention. Concurrently, repeat laboratory results show worsened electrolyte imbalances, with potassium levels dropping to 2.8 mmol/L and sodium decreasing to 130 mmol/L, exacerbating concerns about potential cardiac complications and further mental status changes.
Given these developments, the healthcare team intensifies their focus on correcting the patient's electrolyte imbalances and optimizing her fluid resuscitation. An aggressive electrolyte replacement regimen is initiated, alongside continuous cardiac monitoring to detect any early signs of arrhythmias. The team also discusses the possibility of transitioning to a more potent antibiotic regimen, considering the patient's lack of clinical improvement. As these interventions unfold, the clinical reasoning process emphasizes the need for comprehensive management of both the underlying infectious process and the emerging complications, underscoring the importance of a multidisciplinary approach in stabilizing the patient.
Section 3
As the healthcare team continues to closely monitor the patient, they observe a change in her status that warrants immediate attention. Despite the aggressive electrolyte replacement and fluid management strategies, the patient exhibits further deterioration in her mental status, becoming increasingly confused and disoriented. Her Glasgow Coma Scale (GCS) score drops to 12, signaling a significant decline in neurological function. Vital signs indicate a heart rate of 116 bpm, respiratory rate of 24 breaths per minute, blood pressure at 88/60 mmHg, and oxygen saturation has dropped to 90% on 4L of oxygen via nasal cannula. The combination of tachycardia, hypotension, and hypoxemia raises concerns about advancing sepsis or the onset of septic shock.
In light of these changes, the healthcare team prioritizes further diagnostic evaluation and adjustments to the treatment plan. A repeat arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 32 mmHg, and HCO3- of 18 mEq/L, indicating a metabolic acidosis with a compensatory respiratory alkalosis. The patient is also noted to have a rising white blood cell count of 22,000/mm3, suggesting an escalating inflammatory response. With these findings, the team initiates broad-spectrum intravenous antibiotics to cover a wider range of potential pathogens and considers the addition of vasopressor support to stabilize the patient’s hemodynamics.
This change in patient status necessitates a re-evaluation of the current treatment strategy, emphasizing the need for ongoing collaboration among the multidisciplinary team. The possibility of escalating to intensive care for closer monitoring and advanced interventions is discussed, as the team remains focused on reversing the patient's decline and preventing further complications. The clinical reasoning process now centers on the delicate balance between aggressive treatment of the infection and supportive care to address the patient's systemic response, highlighting the complexity and dynamic nature of managing severe cases of community-acquired C. diff infection.
Section 4
As the healthcare team continues to manage the patient's deteriorating condition, they notice a new complication arising. The patient's abdomen has become increasingly distended and tender, raising concerns about the possibility of toxic megacolon, a severe complication of Clostridioides difficile infection. On physical examination, bowel sounds are hypoactive, and the patient complains of worsening abdominal pain. Given these findings, the team orders an abdominal CT scan to evaluate for colonic dilation and other potential complications such as perforation or ischemia.
The CT scan results reveal significant colonic distention with evidence of thickened bowel walls, consistent with toxic megacolon. In response to this critical finding, the healthcare team urgently consults with the surgical team to assess the need for possible surgical intervention, such as a colectomy. Meanwhile, the patient's hemodynamic status remains precarious, with continued hypotension and tachycardia despite fluid resuscitation, further complicating the clinical picture.
The emergence of toxic megacolon necessitates a shift in the management plan to prioritize both the resolution of the infectious process and the prevention of life-threatening complications. The multidisciplinary team discusses the risks and benefits of surgical intervention versus continued medical management, considering the patient's current instability. This scenario underscores the importance of ongoing assessment and the ability to adapt the treatment strategy in response to evolving clinical situations, emphasizing the need for timely decision-making and collaboration across specialties to optimize patient outcomes.
Section 5
As the healthcare team evaluates the situation, they decide to focus on the patient's response to the initial interventions, particularly the fluid resuscitation and antimicrobial therapy aimed at controlling the Clostridioides difficile infection. Despite these efforts, the patient's hemodynamic status remains unstable, with blood pressure readings persistently low at 85/55 mmHg and a heart rate of 118 beats per minute. The patient's urinary output has decreased significantly, dropping to less than 0.5 mL/kg/hr, indicating a potential progression towards acute kidney injury. These findings suggest that the current medical management may not be sufficient, and the team needs to reassess their approach to stabilize the patient.
In response to the continued hypotension and oliguria, the team implements a more aggressive fluid management strategy, introducing vasopressor support to maintain adequate perfusion pressure. Norepinephrine is initiated as a continuous infusion, and the patient's mean arterial pressure shows slight improvement, though it remains on the lower end of acceptable ranges. Additionally, the team considers the need for electrolyte correction, as laboratory results reveal an elevated lactate level of 4.2 mmol/L and evidence of metabolic acidosis, with a bicarbonate level of 18 mEq/L. These findings indicate ongoing tissue hypoperfusion and metabolic derangement, necessitating ongoing monitoring and adjustments to the treatment plan.
Meanwhile, the surgical team evaluates the patient for potential colectomy, weighing the risks of surgery in the context of the patient's current instability against the possibility of further deterioration if toxic megacolon progresses unchecked. The decision-making process is complex, requiring careful consideration of the patient's overall condition, the likelihood of recovery with medical management alone, and the potential benefits of surgical intervention. The team remains vigilant, continuously reassessing the patient's response to treatment and remaining prepared to intervene surgically if warranted by further changes in the patient's status.